| 1 | Randomized controlled trial/ |
| 2 | Controlled clinical study/ |
| 3 | Random$.ti,ab. |
| 4 | randomization/ |
| 5 | intermethod comparison/ |
| 6 | placebo.ti,ab. |
| 7 | (compare or compared or comparison).ti. |
| 8 | (open adj label).ti,ab. |
| 9 | ((double or single or doubly or singly) adj (blind or blinded or blindly)).ti,ab. |
| 10 | double blind procedure/ |
| 11 | parallel group$1.ti,ab. |
| 12 | (crossover or cross over).ti,ab. |
| 13 | ((assign$ or match or matched or allocation) adj5 (alternate or group$1 or intervention$1 or patient$1 or subject$1 or participant$1)).ti,ab. |
| 14 | (assigned or allocated).ti,ab. |
| 15 | (controlled adj7 (study or design or trial)).ti,ab. |
| 16 | (volunteer or volunteers).ti,ab. |
| 17 | trial.ti. |
| 18 | or/1‐17 |
| 19 | exp breast/ |
| 20 | exp breast disease/ |
| 21 | (19 or 20) and exp neoplasm/ |
| 22 | exp breast tumor/ |
| 23 | exp breast cancer/ |
| 24 | exp breast carcinoma/ |
| 25 | (breast$ adj5 (neoplas$ or cancer$ or carcin$ or tumo$ or metasta$ or malig$)).ti,ab. |
| 26 | or/21‐25 |
| 27 | exp cyclin dependent kinase inhibitor/ |
| 28 | cyclin dependent kinase$ inhibit$.mp. |
| 29 | exp cyclin dependent kinase 4/ |
| 30 | cyclin dependent kinase 4.mp. |
| 31 | exp cyclin dependent kinase 6/ |
| 32 | cyclin dependent kinase 6.mp. |
| 33 | exp palbociclib/ |
| 34 | palbociclib.mp. |
| 35 | exp ribociclib/ |
| 36 | ribociclib.mp. |
| 37 | exp abemaciclib/ |
| 38 | abemaciclib.mp. |
| 39 | or/27‐38 |
| 40 | 18 and 26 and 39 |
| 41 | limit 40 to (human and (conference abstracts or embase)) |